Some analysts see Berkshire Hathaway’s (BRK.A -1.2%) $9B acquisition of Lubrizol (LZ) as...

Some analysts see Berkshire Hathaway’s (BRK.A -1.2%) $9B acquisition of Lubrizol (LZ) as inciting similar deals, but only one stock has surged: NewMarket (NEU +11.7%), seen as one of Lubrizol’s closest competitors. Analysts also point to Omnova (OMN +0.1%), Penford (PENX +0.5%), Huntsman (HUN -0.3%) and Solutia (SOA -0.4%) as possible buyout candidates.
From other sites
Comments (1)
  • Innes Group inc.
    , contributor
    Comment (1) | Send Message
    Lubrizol corp. is currently under investigation, meaning the deal itself may be annulled. The company's board is accused of having breached their fiduciary duties towards their share holders [as it appears that they didn't "shop around" for other buyers before they settled for Berkshire Hathaway's mediocre bid. Let's be honest, Buffett was taking over the company at a bargain 135$/share. Some analysts' projections suggest the stock may be worth as much as 148$/share this time next year. I am not so optimistic [given the information available to me], but I do believe the company has been undervalued in this transaction.

  explains the matter further.


    Innes Group inc.


    17 Mar 2011, 01:36 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs